SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-24-000265
Filing Date
2024-04-05
Accepted
2024-04-05 20:50:16
Documents
2
Period of Report
2024-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 50475
2 EX-24 DOCUMENT attachment1.htm EX-24 5158
  Complete submission text file 0000899243-24-000265.txt   57210
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INCYTE CORPORATION 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address
FRIEDMAN PAUL A (Reporting) CIK: 0001236927 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 24827899